Therapeutic agents for inner ear disorders containing an IL-6 antagonist as an active ingredient
US7498031B2 · kind B2 · utility
39Cited by
3References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 24, 2005 |
| Grant date | Mar 3, 2009 |
| Priority date | — |
| Expiry date | Mar 24, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A therapeutic and/or preventive agent for inner ear disorders comprising an IL-6 antagonist, preferably an anti-IL-6R antibody, as an active ingredient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.